migraine
‘An exciting time’: a new era in treating migraine
New treatment options and changes to the scheduling of existing medicines are heralding changes to the outlook for patients who experience migraine, writes Megan Haggan “It’s an exciting time in …
Scheduling shakeup
A raft of new scheduling decisions have been revealed, with a number of medicines set to be downscheduled, but no alteration to planned paracetamol changes A number of decisions have …
The dark spot
‘Being a migraine sufferer does encourage you to make the most of the good days’: Angelo Pricolo reflects on a life of dealing with migraine, both personally, and as a …
Research Roundup
Debbie Rigby rounds up the latest in research news Interprofessional collaboration within general practice teams following the inclusion of non-dispensing pharmacists This survey explored collaboration between pharmacists and health professionals …
Research Roundup
Debbie Rigby rounds up the latest in research news Clinical Impact of medication reviews with follow-up in cardiovascular older patients in primary care This cluster-randomised controlled trial was conducted in …
Menstrual migraine
Migraine attacks occurring around menstruation are more severe and harder to treat. This article looks at the presentation and types of menstrual migraine, as well as common medications used for …
Headache and migraine: Make some headroom
Pharmacists can make a difference to the burden of headache and migraine, given research shows GPs aren’t adequately trained and 50% of patients haven’t even been properly diagnosed. The 2020-21 …
Research Roundup
Debbie Rigby rounds up the latest in research news Multiple short courses of corticosteroids in children Short courses of oral steroids (less than two weeks) in children are very unlikely …
Research Roundup
Debbie Rigby rounds up the latest in research news Migraine management Drugs can be used to treat acute migraine, or they can be used prophylactically to reduce the frequency and …
Mixed results on scheduling
Migraine treatment and immediate release ibuprofen set to be downscheduled, but no change to status of another high profile medicine The migraine treatment eletriptan is to move to Schedule 3 …
Downscheduling welcomed
Downscheduling of migraine treatments begins on 1 Feb The Pharmacy Guild of Australia welcomed the confirmed decision to down-schedule the migraine treatments sumatriptan and zolmitriptan to S3, or pharmacist-only, medicines. …
Taking responsibility
Scheduling decisions see migraine treatments move to Pharmacist Only status, while liquid paracetamol S2 sales to be restricted from mid-year Proposed medicines scheduling changes will see the migraine treatments Sumatriptan …